-
Subject Areas on Research
-
A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
-
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.
-
A synergistic effect of total lymphoid irradiation, cyclosporine, and splenectomy in a hamster-to-rat hepatic xenograft model.
-
Acute and chronic graft-versus-host disease in man.
-
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
-
Allogeneic small bowel transplantation with cyclosporine and donor whole-body irradiation.
-
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
-
Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture.
-
Association between cyclosporin neurotoxicity and hypomagnesaemia.
-
Cadaveric renal transplantation in the cyclosporine and OKT3 eras: an update of the University of Wisconsin-Madison experience.
-
Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories.
-
Combined total lymphoid irradiation and cyclosporine promote xenograft survival.
-
Cyclosporin-A increases synthesis of 1,25-dihydroxyvitamin D3 in the rat and mouse.
-
Cyclosporine A inhibits Ca2+-dependent stimulation of the Na+/H+ antiport in human T cells.
-
Cyclosporine augments receptor-mediated cellular Ca2+ fluxes in isolated hepatocytes.
-
Cyclosporine inhibition of CH series murine B-cell lymphomas.
-
Cyclosporine inhibition of a murine B cell lymphoma.
-
Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up.
-
Cyclosporine nephrotoxicity: a workshop to discuss mechanisms, diagnosis, and treatment.
-
Cyclosporine therapy and the development of interstitial fibrosis in renal allografts.
-
Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation.
-
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
-
Decreased kallikrein excretion in renal transplant treated with cyclosporine A.
-
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.
-
Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients.
-
Effect of cyclosporine on bile secretion in rats.
-
Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients.
-
Effects of cyclosporine in experimental cryptococcal meningitis.
-
Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group.
-
Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity.
-
Frequency of hypercholesterolemia after cardiac transplantation.
-
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
-
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts.
-
Hemolytic anemia is not a frequent complication of ABO unmatched renal allografts from living related donors.
-
Identification of cyclosporin C from Amphichorda felina using a Cryptococcus neoformans differential temperature sensitivity assay.
-
Immunosuppressive therapy and lipoprotein abnormalities after cardiac transplantation.
-
Improvements in digital vasculature observed using micro magnetic resonance angiography after high-dose immunosuppression for severe systemic sclerosis.
-
Infection and cyclosporine.
-
Inhibition of in vitro NZB antibody responses by cyclosporine.
-
Inhibition of in vitro anti-DNA B-cell responses by cyclosporine.
-
Isoflurane alters the kinetics of oral cyclosporine.
-
Liver transplantation.
-
Macrophage migration into hepatic xenografts in the hamster-to-rat combination.
-
Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.
-
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
-
Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.
-
Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
-
Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis.
-
Orthotopic liver transplantation in patients 60 years of age and older.
-
Orthotopic liver transplantation in patients over 60 years of age.
-
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.
-
Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420.
-
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.
-
Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.
-
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
-
Predictive factors for immunologic graft failure in cadaver renal transplant recipients.
-
Prolonged heart xenograft survival using combined total lymphoid irradiation and cyclosporine.
-
Prolonged survival of hepatic xenografts in the hamster to rat combination: efficacy of cyclosporine in combination with splenectomy.
-
Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808.
-
Renal failure in cardiac transplantation.
-
Renal transplantation in the American black.
-
Retina-specifically expressed novel subtypes of bovine cyclophilin.
-
Significant prolongation of hamster liver transplant survival in Lewis rats by total-lymphoid irradiation, cyclosporine, and splenectomy.
-
Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
-
The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.
-
The effect of TLI and cyclosporine on xenograft survival.
-
The effect of cyclosporine, total lymphoid irradiation, and cobra venom factor on hyperacute rejection.
-
The importance of class I and class II HLA in cadaveric renal transplantation.
-
The influence of RS-61443 on antibody-mediated rejection.
-
The pathophysiology and treatment of graft-versus-host disease.
-
The spectrum of ciclosporin nephrotoxicity.
-
Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
-
Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model.
-
Total lymphoid irradiation for cardiac xenotransplantation in nonhuman primates.
-
Transplantation of rat insulinoma allografts with cyclosporin A.
-
Transplantation of the entire small bowel in inbred rats using cyclosporine.
-
Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.
-
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
-
Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone.
-
Tubular markers in renal transplant patients under cyclosporine.
-
Use of OKT3 in kidney, pancreas, and liver transplantation.
-
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
-
Xenograft survival in two species combinations using total-lymphoid irradiation and cyclosporine.